Építés alatt – nem éles oldal
Belépés
Taking people in Egyesült ÁllamokNo phase

Long-term COVID and Rehabilitation

Key facts

Where
Salt Lake City, Egyesült ÁllamokSee the site

Where in Egyesült Államok

  • VA Salt Lake City Health Care System, Salt Lake City, UTSalt Lake City, Egyesült ÁllamokTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
VA Office of Research and Development
Trial code
NCT05373043
Record updated
2026. július 30.
Original description
The proposed focuses on improving both morbidity and mortality in older Veterans and those recovering from COVID-19 by developing rehabilitation therapies to augment vascular endothelial function by combating the oxidative stress and inflammation associated with aging and further induced by COVID-19. The investigators expected outcomes will have an important positive impact because they will provide scientifically sound recommendations for rehabilitation to improve vascular endothelial function and minimize the long-term consequences of COVID-19.Read full original descriptionShow less

Evaluating the Long-term Health Consequences of COVID-19 and Rehabilitation Therapies to Speed Convalescence

The proposed focuses on improving both morbidity and mortality in older Veterans and those recovering from COVID-19 by developing rehabilitation therapies to augment vascular endothelial function by combating the oxidative stress and inflammation associated with aging and further induced by COVID-19. The investigators expected outcomes will have an important positive impact because they will provide scientifically sound recommendations for rehabilitation to improve vascular endothelial function and minimize the long-term consequences of COVID-19.

Inclusion: Long-COVID and COVID-recovered patients must have SARS-CoV-19 positive test near the time of COVID-19 diagnosis; Long-COVID and COVID-recovered patients must be 3-12 months post-initial COVID-19 diagnosis; Ability to sign informed consent.

Exclusion: Any other condition or event considered exclusionary by the PIs or a physician; Unstable (<6 months) or severe coronary artery disease (CAD-RADS score = 4A), peripheral artery disease (Ankle Brachial Index <0.40), cerebrovascular disease (identified by previous stroke in last 12 months), severe COPD (=Stage III), uncontrolled hypertension (>160/100 mmHg), chronic kidney disease requiring dialysis, severe renal insufficiency (creatinine clearance <30 by the Cockcroft-Gault formula), Alzheimer's disease, dementia; BMI >45 kg/m2; Orthopedic limitations that would prohibit exercise; Current smokers and individuals that stopped smoking in the last 10 years; Already taking Mito-Q or unwilling to cease dietary supplements for participation.

ClinicalTrials.gov NCT05373043